SEPTEMBER 18, 2015

Company

Akari Therapeutics Plc

Filed

September 29, 2015

Accession Number

0000914760-15-000279

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →